BioMarker Strategies, LLC, today announced that the Japan Patent Office has granted new patents covering the Company’s SnapPath® Cancer Diagnostics System technology and its PathMAP® Functional Signaling Profile technology.
{iframe}http://www.businesswire.com/news/home/20170831006091/en/BioMarker-Strategies-Announces-New-Patents-Granted-Japan{/iframe}